Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26F9V87
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,619
Award facts
- Contract value 100% obligated
- $13,619.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 9, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL pharmaceutical supplies with a ceiling value of $13,619.04. The order is not set-aside and utilizes firm fixed pricing, with an ultimate completion date of January 12, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle through December 31, 2031, which serves as the primary procurement mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that supplies a comprehensive range of medications, vaccines, and medical devices to federal agencies, particularly military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and demonstrates significant capability in fulfilling varied pharmaceutical requirements across multiple therapeutic domains. The DLA awards delivery orders under the larger IDC vehicle to procure specific pharmaceutical products as needed by the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, enabling efficient and flexible medical supply chain management across the defense enterprise.
Quick answers
Who was awarded contract SPE2DR26F9V87?
SPE2DR26F9V87 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9V87 worth?
The government has obligated $13,619 on SPE2DR26F9V87.
Is contract SPE2DR26F9V87 an order under another contract?
Yes. SPE2DR26F9V87 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V87 competed?
The extent of competition for SPE2DR26F9V87 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award